Yair Herishanu

24PUBLICATIONS
70CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursVeterinary mycologyInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 10, 2026
Real-World Outcomes of Venetoclax-Based Therapy in Treatment-Naïve and Relapsed/Refractory CLL/SLL: Interim Results From the Prospective REVEAL Study.

|Jan 24, 2024
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL.

A Campanella, A Capasso, S Heltai

|Sep 29, 2023
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

Andrea Visentin, Thomas Chatzikonstantinou, Lydia Scarfò

|Apr 12, 2023
Improved outcomes in patients with chronic lymphocytic leukaemia infected during the omicron BA.5 subvariant surge.

Yotam Bronstein, Shai Levi, Yair Herishanu

|Mar 25, 2023
Response rates of extra-nodal diffuse large B cell lymphoma to anti-CD19-CAR T cells: A real word retrospective multicenter study.

Ofrat Beyar Katz, Chava Perry, Sigal Grisariu-Greenzaid

|Nov 09, 2022
Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study.

Shai Levi, Yotam Bronstein, Neta Goldschmidt

Pageof 4

Frequent Collaborators

5 joint publications

Francesca Romana Mauro

5 joint publications

Andrea Visentin

5 joint publications

Marzia Varettoni

5 joint publications

Tamar Tadmor